1,710
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma

&
Pages 43-50 | Received 01 Aug 2017, Accepted 13 Dec 2017, Published online: 20 Dec 2017

References

  • Ambros V. 2004. The functions of animal microRNAs. Nature. 431:350–355.
  • Bao H, Li X, Li H, Xing H, Xu B, Zhang X, Liu Z. 2017. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX. J Biosci. 42:103–111.
  • Choi HJ, Eun J-S, Kim DK, Li RH, Shin T-Y, Park H, Cho N-P, Soh Y. 2008. Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1alpha in human osteosarcoma cells. Eur J Pharmacol. 579:58–65.
  • Dashtdar M, Dashtdar MR, Dashtdar B, Kardi K, Shirazi Mk. 2016. The concept of wind in traditional Chinese medicine. J Pharmacopuncture. 19:293–302.
  • Friedman RJ, Rigel DS, Kopf AW. 1985. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 35:130–151.
  • GBD 2015 Mortality and Causes of Death Collaborators. 2016. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388:1459–1544.
  • Geng Y-d, Yang L, Zhang C, Kong L-Y. 2014. Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by icariside II results in reduced cell proliferation of osteosarcoma cells. Food Chem Toxicol. 73:7–16.
  • Gordon KJ, Kirkbride KC, How T, Blobe GC. 2009. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis. 30:238–248.
  • Herrera B, van Dinther M, Ten Dijke P, Inman GJ. 2009. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res. 69:9254–9262.
  • Kim S-H, Ahn KS, Jeong S-J, Kwon T-R, Jung JH, Yun S-M, Han I, Lee S-G, Kim DK, Kang M, et al. 2011. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Eur J Pharmacol. 654:10–16.
  • Kozovska Z, Gabrisova V, Kucerova L. 2016. Malignant melanoma: diagnosis, treatment and cancer stem cells. Neoplasma. 63:510–517.
  • Lee K-S, Lee H-J, Ahn KS, Kim S-H, Nam D, Kim DK, Choi D-Y, Ahn K-S, Lu J, Kim S-H, et al. 2009. Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett. 280:93–100.
  • Li B, Zhang S, Shen H, Li C. 2017. MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3. Biochem Biophys Res Commun. 484:241–247.
  • Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, Massagué J. 1996. A human mad protein acting as a BMP-regulated transcriptional activator. Nature. 381:620–623.
  • Liu F, Chen N, Xiao R, Wang W, Pan Z. 2016. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8. Biochem Biophys Res Commun. 480:87–93.
  • Madhavan D, Peng C, Wallwiener M, Zucknick M, Nees J, Schott S, Rudolph A, Riethdorf S, Trumpp A, Pantel K, et al. 2016. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis. Carcinogenesis. 37:461–470.
  • Miller AJ, Mihm MC Jr. 2006. Melanoma. N Engl J Med. 355:51–65.
  • Ohtsuka M, Ling H, Doki Y, Mori M, Calin GA. 2015. MicroRNA processing and human cancer. J Clin Med. 4:1651–1667.
  • Pan Y, Zhang J, Fu H, Shen L. 2016. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process. Onco Targets Ther. 9:6247–6255.
  • Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC, Sober AJ. 1987. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA. 258:3146–3154.
  • Sharma P, Saraya A, Sharma R. 2016. Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer. Indian J Med Res. 143:S91–S103.
  • Singh S, Zafar A, Khan S, Naseem I. 2017. Towards therapeutic advances in melanoma management: an overview. Life Sci. 174:50–58.
  • Song J, Shu L, Zhang Z, Tan X, Sun E, Jin X, Chen Y, Jia X. 2012. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem Biol Interact. 199:9–17.
  • Sun X, Liu D, Xue Y, Hu X. 2017. Enforced miR-144-3p expression as a non-invasive biomarker for the acute myeloid leukemia patients mainly by targeting NRF2. Clin Lab. 63:679–687.
  • Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, Bart RS. 2001. Ultraviolet A and melanoma: a review. J Am Acad Dermatol. 44:837–846.
  • Wu J, Guan M, Wong PF, Yu H, Dong J, Xu J. 2012. Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. Food Chem Toxicol. 50:3019–3024.
  • Wu J, Song T, Liu S, Li X, Li G, Xu J. 2015. Icariside II inhibits cell proliferation and induces cell cycle arrest through the ROS-p38-p53 signaling pathway in A375 human melanoma cells. Mol Med Rep. 11:410–416.
  • Wu J, Xu J, Eksioglu EA, Chen X, Zhou J, Fortenbery N, Wei S, Dong J. 2013. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways. Nutr Cancer. 65:110–117.
  • Zhang H, Xing W-W, Li Y-S, Zhu Z, Wu J-Z, Zhang Q-Y, Zhang W, Qin L-P. 2008. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts. Maturitas. 61:334–339.